Global Circadian Rhythm Sleep Treatment Market Growth (Status and Outlook) 2025-2031

Global Circadian Rhythm Sleep Treatment Market Growth (Status and Outlook) 2025-2031

The global Circadian Rhythm Sleep Treatment market size is predicted to grow from US$ 805 million in 2025 to US$ 1306 million in 2031; it is expected to grow at a CAGR of 8.4% from 2025 to 2031.

Circadian rhythm disorders are disruptions in a patient's internal clock that regulates a variety of biological processes, which makes it difficult to follow normal sleep patterns. The circadian rhythm disorders include: Delayed sleep-wake phase, Advanced sleep-wake phase, Irregular sleep-wake rhythm, Non-24-hour sleep-wake rhythm, Shift work, Jet lag. The most common treatments for circadian rhythm disorders are healthy lifestyle changes, bright light therapy, and melatonin. It is aim to reset people's sleep-wake rhythm to align with the environment.

The global circadian rhythm sleep treatment market is set for continued growth driven by increased awareness, advancements in treatment options, and technological innovations. The emphasis on personalized medicine, improved diagnostic tools, and a growing focus on sleep health and wellness are key factors contributing to market expansion. However, challenges such as regional disparities in awareness and the cost of advanced treatments remain. Ongoing research and development will play a crucial role in shaping the future of the market.Global key players of circadian rhythm sleep treatment include Takeda Pharmaceutical, NBTY, Nature Made (Pharmavite) and Vicks (Procter & Gamble), etc. The top four players hold a share over 40%. In terms of product type, drug therapy is the largest segment, occupied for a share of approximately 80%, and in terms of application, delayed sleep phase syndrome has a share about 50%.

LPI (LP Information)' newest research report, the “Circadian Rhythm Sleep Treatment Industry Forecast” looks at past sales and reviews total world Circadian Rhythm Sleep Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Circadian Rhythm Sleep Treatment sales for 2025 through 2031. With Circadian Rhythm Sleep Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circadian Rhythm Sleep Treatment industry.

This Insight Report provides a comprehensive analysis of the global Circadian Rhythm Sleep Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circadian Rhythm Sleep Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circadian Rhythm Sleep Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circadian Rhythm Sleep Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circadian Rhythm Sleep Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Circadian Rhythm Sleep Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Drug Therapy
Light Therapy

Segmentation by Application:
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Koninklijke Philips
Luminette
Sleepace
PEGASI
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health

Please note: The report will take approximately 2 business days to prepare and deliver.